http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102775490-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102775490-B |
titleOfInvention | Secretory protein with migration activity and application thereof |
abstract | The invention provides a chemotactic leucocyte and an FAM19A5 secretory protein of amino acid sequence as shown in SEQ ID NO: 1 of tumor, a polynucleotide coding the protein, and a polynucleotide-containing genetic engineering carrier. The invention further relates to a drug composite, the protein or polynucleotide-containing genetic engineering carrier and/or host cell, and a pharmaceutically acceptable salt, carrier or excipient. The invention further relates to a method for detecting the expression level change of the protein or the polynucleotide in vitro. Furthermore, the protein or the polynucleotide can be used for preventing and/or curing the virus infection, the allergic diseases, the inflammatory response, the transplant rejection, the cerebral disease, the autoimmunity disease, the tumor metastasis, the immune adjustment, the proliferation and differentiation of stem cells, the osteoporosis, the obesity, the insulin resistance and the cardiovascular disease such as the arteriosclerosis, the angiosteosis and the like, and can be used for commercialized agent to research the symptoms. The protein or the polynucleotide can be further taken as a target to develop the compound, the antibody, the polypeptide drug and the commercialized reagent. |
priorityDate | 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 526.